Arca
Skip to content
Tools
Tools

ROTEM sigma Thromboelastometry System

System, Multipurpose For In Vitro Coagulation Studies. 510(k) K201440, from Tem Innovations GmbH (Munich, DE). Product code JPA, class 2.

As of Nov 18, 2026, K201440 is an FDA 510(k) held by Tem Innovations GmbH, substantially equivalent on Jul 8, 2022 after 767 days, with no recalls tied to it in FDA's recall database.

  • Review time: 767 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The ROTEM sigma thromboelastometry system is a fully integrated and automated in vitro diagnostic system designed to monitor and analyze a patient’s coagulation status by measuring the viscoelastic properties of a 3.2% citrated venous or arterial whole blood sample.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other JPA clearances

The newest 510(k)s for the same product code; their median review was 158 days; see every JPA device

Record

Type
Traditional
Received
Jun 1, 2020
Review panel
Hematology
Regulation
21 CFR 864.5425

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.